The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
99 | 91 | 99 | 89 |
Growth
|
9 | 27 | 45 | 77 |
Safety
|
38 | 39 | 41 | 7 |
Sentiment
|
22 | 71 | 90 | 55 |
|
32 | 65 | 88 | 65 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
9 | 73 | 79 | 46 |
Opinions Change
|
61 | 23 | 72 | 50 |
Pro Holdings
|
n/a | 80 | 73 | 26 |
Market Pulse
|
17 | 70 | 42 | 81 |
Sentiment
|
22 | 71 | 90 | 55 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
99 | 91 | 99 | 89 |
Growth
|
9 | 27 | 45 | 77 |
|
38 | 39 | 41 | 7 |
Combined
|
40 | 53 | 75 | 71 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
95 | 97 | 93 | 81 |
Price vs. Earnings (P/E)
|
89 | 77 | 82 | 78 |
Price vs. Book (P/B)
|
91 | 89 | 91 | 91 |
Dividend Yield
|
88 | 82 | 81 | 76 |
Value
|
99 | 91 | 99 | 89 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
36 | 26 | 54 | 78 |
Profit Growth
|
10 | 39 | 48 | 76 |
Capital Growth
|
22 | 45 | 21 | 21 |
Stock Returns
|
5 | 39 | 79 | 79 |
Growth
|
9 | 27 | 45 | 77 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
23 | 24 | 34 | 36 |
Refinancing
|
96 | 88 | 90 | 1 |
Liquidity
|
22 | 24 | 28 | 24 |
|
38 | 39 | 41 | 7 |
Discover high‑ranked alternatives to Aspen Pharmacare and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.